Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-022446
Filing Date
2020-08-14
Accepted
2020-08-14 18:08:47
Documents
1
Period of Report
2020-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8598
  Complete submission text file 0000899243-20-022446.txt   9912
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 680 SOUTH FOURTH STREET LOUISVILLE KY 40202
Business Address
DIAZ PAUL J (Reporting) CIK: 0001194247 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 201107081